Resistance to Immunotherapeutic Antibodies in Cancer

ISBN: 9781489987327

$189.00 $160.65

​​​​The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance. Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book covers the common and unique features of mAbs agains various cancer, gives the latest developments on the molecular, biochemical and genetic mechanisms of resistance by various mAbs, as well as discuss novel mAbs to overcome resistance.

Categories: ,
Title:
Resistance to Immunotherapeutic Antibodies in Cancer
ISBN-13:
9781489987327
Author:
Publisher:
Springer New York
Published Date:
20150822
Edition:
1
Binding
Paperback / softback
Pages:
202
Language:
English
Product Dim.:
9.25 H x 6.10 W (inches)

Dr. Benjamin Bonavida is a professor at UCLA's David Geffen School of Medicine for the Department of Microbiology, Immunology, & Molecular Genetics. His other appointments include being a member of the Department of Defense Congressionally Directed Medical Research Program, Member of the National Cancer Institute's SPORE Program, member of the International Scientific Advisory Board of the Israel Cancer Research Foundation, to name a few. He's currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals. In his career, he's published over 450 papers and reviews, and he's also edited two books with Springer in the past. For more information, please see the CV attached herewith.

Special Offers and Promotions

Our print to order bookstore saves you money. There are currently no special offers for Resistance to Immunotherapeutic Antibodies in Cancer

Editorial Reviews

Thank you for selecting our online bookstore. Currently, there are no editorial book reviews for Resistance to Immunotherapeutic Antibodies in Cancer

About the Author

Dr. Benjamin Bonavida is a professor at UCLA’s David Geffen School of Medicine for the Department of Microbiology, Immunology, & Molecular Genetics. His other appointments include being a member of the Department of Defense Congressionally Directed Medical Research Program, Member of the National Cancer Institute’s SPORE Program, member of the International Scientific Advisory Board of the Israel Cancer Research Foundation, to name a few. He’s currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals. In his career, he’s published over 450 papers and reviews, and he’s also edited two books with Springer in the past. For more information, please see the CV attached herewith.

About Pubgraphics Direct

PGDirect is an online bookstore that has embraced the concept of direct to consumer selling for self-published books, softcover and hardcover books, specialty books, children's books, hard to find books, college textbooks, print on demand books and more.

Your Cart


Fatal error: Allowed memory size of 536870912 bytes exhausted (tried to allocate 82 bytes) in /home/pgdirect/public_html/wp-includes/wp-db.php on line 1972